OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age
Flor M. Muñoz, Lawrence Sher, Charu Sabharwal, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 7, pp. 621-634
Open Access | Times Cited: 63
Flor M. Muñoz, Lawrence Sher, Charu Sabharwal, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 7, pp. 621-634
Open Access | Times Cited: 63
Showing 1-25 of 63 citing articles:
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 118-118
Open Access | Times Cited: 22
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 118-118
Open Access | Times Cited: 22
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Fengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 12, pp. 1075-1088
Open Access | Times Cited: 31
Fengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 12, pp. 1075-1088
Open Access | Times Cited: 31
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
(2024)
Open Access | Times Cited: 10
Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, et al.
(2024)
Open Access | Times Cited: 10
Vaccination against COVID-19 — risks and benefits in children
Alasdair Munro, Christine E. Jones, Saul N. Faust
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1107-1112
Open Access | Times Cited: 9
Alasdair Munro, Christine E. Jones, Saul N. Faust
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1107-1112
Open Access | Times Cited: 9
mRNA vaccines against respiratory viruses
Jennifer A. Whitaker, Hana M. El Sahly, C. Mary Healy
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 5, pp. 385-393
Closed Access | Times Cited: 17
Jennifer A. Whitaker, Hana M. El Sahly, C. Mary Healy
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 5, pp. 385-393
Closed Access | Times Cited: 17
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16
Current state of COVID-19 in children: 4 years on
Annabel Powell, Alexander C. Dowell, Paul Moss, et al.
Journal of Infection (2024) Vol. 88, Iss. 5, pp. 106134-106134
Open Access | Times Cited: 6
Annabel Powell, Alexander C. Dowell, Paul Moss, et al.
Journal of Infection (2024) Vol. 88, Iss. 5, pp. 106134-106134
Open Access | Times Cited: 6
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data
Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Fengcai Zhu, Ting Huang, Pengfei Jin, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 43-43
Open Access
Fengcai Zhu, Ting Huang, Pengfei Jin, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 43-43
Open Access
BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety
Esraa Alkhalil, Bashar Jarad, Tala Al Saleh, et al.
Prospects in Pharmaceutical Sciences (2025) Vol. 23, Iss. 1, pp. 31-46
Open Access
Esraa Alkhalil, Bashar Jarad, Tala Al Saleh, et al.
Prospects in Pharmaceutical Sciences (2025) Vol. 23, Iss. 1, pp. 31-46
Open Access
COVID-19 Vaccination in Korea
Wan Beom Park, Young Hoon Hwang, Hee Jin Cheong
Infection and Chemotherapy (2023) Vol. 55, Iss. 1, pp. 135-135
Open Access | Times Cited: 14
Wan Beom Park, Young Hoon Hwang, Hee Jin Cheong
Infection and Chemotherapy (2023) Vol. 55, Iss. 1, pp. 135-135
Open Access | Times Cited: 14
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
Yeqing Sun, Weijin Huang, Hongyu Xiang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 554-554
Open Access | Times Cited: 4
Yeqing Sun, Weijin Huang, Hongyu Xiang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 554-554
Open Access | Times Cited: 4
The effect of perceived social support and health literacy on parental COVID-19 vaccine hesitation in preschool children: a cross-sectional study
Jiayue Chen, Quqing Wang, Nan Jiang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Jiayue Chen, Quqing Wang, Nan Jiang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies
Martin Neil, Scott McLachlan, Norman Fenton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Martin Neil, Scott McLachlan, Norman Fenton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
Lu Zhang, Alexandra Dopfer‐Jablonka, Inga Nehlmeier, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 487-487
Open Access | Times Cited: 3
Lu Zhang, Alexandra Dopfer‐Jablonka, Inga Nehlmeier, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 487-487
Open Access | Times Cited: 3
Trends in Pediatric Hospital Admissions Caused or Contributed by SARS-CoV-2 Infection in England
Harrison Wilde, Christopher Tomlinson, Bilal A. Mateen, et al.
The Journal of Pediatrics (2024) Vol. 276, pp. 114370-114370
Open Access | Times Cited: 3
Harrison Wilde, Christopher Tomlinson, Bilal A. Mateen, et al.
The Journal of Pediatrics (2024) Vol. 276, pp. 114370-114370
Open Access | Times Cited: 3
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies
Courtney E. Harris, Abi Vijenthira, Shin Yeu Ong, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 7
Courtney E. Harris, Abi Vijenthira, Shin Yeu Ong, et al.
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 7
Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years
Liang En Wee, Nicole K. Y. Tang, Deanette Pang, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 12, pp. 1324-1324
Closed Access | Times Cited: 7
Liang En Wee, Nicole K. Y. Tang, Deanette Pang, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 12, pp. 1324-1324
Closed Access | Times Cited: 7
Emerging and re-emerging pediatric viral diseases: a continuing global challenge
Seth A. Hoffman, Yvonne Maldonado
Pediatric Research (2023) Vol. 95, Iss. 2, pp. 480-487
Open Access | Times Cited: 6
Seth A. Hoffman, Yvonne Maldonado
Pediatric Research (2023) Vol. 95, Iss. 2, pp. 480-487
Open Access | Times Cited: 6
Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years
Sara Y. Tartof, Timothy B. Frankland, Jeff Slezak, et al.
JAMA (2023) Vol. 330, Iss. 13, pp. 1282-1282
Open Access | Times Cited: 5
Sara Y. Tartof, Timothy B. Frankland, Jeff Slezak, et al.
JAMA (2023) Vol. 330, Iss. 13, pp. 1282-1282
Open Access | Times Cited: 5
Benefit–Risk Assessment of mRNA COVID-19 Vaccines in Children Aged 6 Months to 4 Years in the Omicron Era
Taito Kitano, Daniel A. Salmon, Matthew Z. Dudley, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 2, pp. 129-135
Open Access | Times Cited: 1
Taito Kitano, Daniel A. Salmon, Matthew Z. Dudley, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 2, pp. 129-135
Open Access | Times Cited: 1
Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage
Yasuhito Fujii, Hidetoshi Ishigaki, Isao Miyairi, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 7, pp. 646-650
Closed Access | Times Cited: 1
Yasuhito Fujii, Hidetoshi Ishigaki, Isao Miyairi, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 7, pp. 646-650
Closed Access | Times Cited: 1
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age
Trisha Dalapati, Caitlin A. Williams, Elena E. Giorgi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 6
Closed Access | Times Cited: 1
Trisha Dalapati, Caitlin A. Williams, Elena E. Giorgi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 6
Closed Access | Times Cited: 1
COVID-19 vaccine updates for people under different conditions
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 1
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 1
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126165-126165
Open Access | Times Cited: 1
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126165-126165
Open Access | Times Cited: 1
